Osimertinib in Stage III EGFR-Mutated NSCLC - Game, Set, Match

MeSH terms

• Acrylamides / therapeutic use
• Aniline Compounds / therapeutic use
• Antineoplastic Agents* / therapeutic use
• Carcinoma, Non-Small-Cell Lung* / drug therapy
• Carcinoma, Non-Small-Cell Lung* / genetics
• Carcinoma, Non-Small-Cell Lung* / pathology
• ErbB Receptors* / antagonists & inhibitors
• ErbB Receptors* / genetics
• Humans
• Indoles
• Lung Neoplasms* / drug therapy
• Lung Neoplasms* / genetics
• Lung Neoplasms* / pathology
• Maintenance Chemotherapy / methods
• Maintenance Chemotherapy / standards
• Mutation
• Neoplasm Staging
• Piperazines / therapeutic use
• Pyrimidines
• Standard of Care
• Tyrosine Kinase Inhibitors* / therapeutic use